Publication | Closed Access

Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles

NanoparticlesNanomedicineMesoporous Silica NanoparticlesEngineeringTherapeutic NanomaterialsNano-drug DeliveryTumor TargetingRadiation OncologySynchronized ReleaseEfferocytosis BlockadeBiomolecular Engineering